I. Juhan-Vague
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management 3
- Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms 4
- Hemophilia Treatment and Research 3
- Epidemiology top 10%
- Adipokines, Inflammation, and Metabolic Diseases 3
-
- Blood properties and coagulation 5
-
- Atrial Fibrillation Management and Outcomes 3
-
- Lipoproteins and Cardiovascular Health 3
- Heparin-Induced Thrombocytopenia and Thrombosis 2
I. Juhan-Vague
26 papers receiving 827 citations
Peers
Comparison fields: 5 of 87
- Internal Medicine 81
- Hematology 190
- Cancer Research 159
- Endocrinology, Diabetes and Metabolism 165
- Epidemiology 317
Countries citing papers authored by I. Juhan-Vague
This map shows the geographic impact of I. Juhan-Vague's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Juhan-Vague with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Juhan-Vague more than expected).
Fields of papers citing papers by I. Juhan-Vague
This network shows the impact of papers produced by I. Juhan-Vague. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Juhan-Vague. The network helps show where I. Juhan-Vague may publish in the future.
Co-authorship network
The 25 scholars most cited alongside I. Juhan-Vague, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 277 | |
| 2 | 2001 | 31 | |
| 3 | 2000 | 275 | |
| 4 | Activation of coagulation in decompression illness. | 1998 | 19 |
| 5 | 1995 | 15 | |
| 6 | [Dyslipidemia, lipid lowering drugs and thrombosis]. | 1995 | 5 |
| 7 | [Lipid indicators of vascular risk. A cross-sectional study of a group of coronary patients, a group of subjects with normal coronary angiography and a control group]. | 1992 | 1 |
| 8 | [Klinefelter's syndrome and leg ulcers: role of blood coagulation disorders]. | 1992 | 5 |
| 9 | 1991 | 1 | |
| 10 | [Disseminated intravascular coagulation masking neonatal hemophilia]. | 1991 | 2 |
| 11 | 1990 | 26 | |
| 12 | 1988 | 54 | |
| 13 | 1988 | 4 | |
| 14 | [The effect of pentoxifylline and propentofylline on the membrane fluidity of red blood cells in uncontrolled insulin-dependent (type 1) diabetic patients]. | 1988 | 2 |
| 15 | 1988 | 1 | |
| 16 | 1987 | 14 | |
| 17 | 1987 | 1 | |
| 18 | [Thromboembolic disease and anomalies of fibrinolysis]. | 1986 | 2 |
| 19 | [Immunologic determination of the protein C of coagulation: detection of deficiencies]. | 1985 | 2 |
| 20 | 1984 | 20 |
About I. Juhan-Vague
I. Juhan-Vague is a scholar working on Internal Medicine, Hematology and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 868 indexed citations. Recurring topics across this work include Blood properties and coagulation (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Atrial Fibrillation Management and Outcomes (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Hemophilia Treatment and Research (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). The work is most often cited by research in Internal Medicine (81 citations), Hematology (190 citations) and Cancer Research (159 citations). I. Juhan-Vague has collaborated with scholars based in France, Belgium and Morocco. Frequent co-authors include Marie‐Christine Alessi, Pierre‐Emmanuel Morange, Alenka Mavri, Isabelle Leduc, Delphine Bastelica, Monique Verdier, B Berthet, Désiré Collen, Jean‐François Renucci and Y Gourmelin. Their work appears in journals such as Thrombosis and Haemostasis, Seminars in Thrombosis and Hemostasis, Journal of Cardiovascular Pharmacology, Infection and Immunity and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.